Bronte Capital Management Pty Ltd. Merrimack Pharmaceuticals Inc Transaction History

Bronte Capital Management Pty Ltd.

  • $1.12 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$3.75 - $6.82 $152,733 - $277,771
40,729 Added 7.58%
578,313 $3.66 Million
Q4 2021

Feb 10, 2022
SELL
$3.75 - $5.1 $42,195 - $57,385
-11,252 Reduced 2.05%
537,584 $2.1 Million
Q2 2021

Aug 09, 2021
SELL
$6.04 - $7.77 $11,131 - $14,320
-1,843 Reduced 0.33%
548,836 $3.51 Million
Q1 2021

Apr 13, 2021
BUY
$6.15 - $8.7 $117,889 - $166,770
19,169 Added 3.61%
550,679 $3.46 Million
Q3 2020

Nov 12, 2020
BUY
$3.1 - $4.3 $1.65 Million - $2.29 Million
531,510 New
531,510 $2.05 Million

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Bronte Capital Management Pty Ltd. Portfolio

Follow Bronte Capital Management Pty Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bronte Capital Management Pty Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bronte Capital Management Pty Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email